341 related articles for article (PubMed ID: 26640389)
41. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma.
Janowska A; Iannone M; Fidanzi C; Romanelli M; Filippi L; Del Re M; Martins M; Dini V
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565234
[TBL] [Abstract][Full Text] [Related]
42. [Secondary malignant tumors of the temporal bone. A histopathologic study and review of the world literature].
Imamura S; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1991 Jul; 94(7):924-37. PubMed ID: 1919860
[TBL] [Abstract][Full Text] [Related]
43. Thyroid metastasis from renal cell carcinoma-A case report after 9 years.
Macedo-Alves D; Koch P; Soares V; Gouveia P; Honavar M; Taveira-Gomes A
Int J Surg Case Rep; 2015; 16():59-63. PubMed ID: 26421840
[TBL] [Abstract][Full Text] [Related]
44. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
Taran JM; Heenan PJ
Cancer; 2001 May; 91(9):1822-5. PubMed ID: 11335909
[TBL] [Abstract][Full Text] [Related]
45. TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases.
Drescher F; Juárez P; Arellano DL; Serafín-Higuera N; Olvera-Rodriguez F; Jiménez S; Licea-Navarro AF; Fournier PG
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260072
[TBL] [Abstract][Full Text] [Related]
46. Tumor cell dormancy.
Gomis RR; Gawrzak S
Mol Oncol; 2017 Jan; 11(1):62-78. PubMed ID: 28017284
[TBL] [Abstract][Full Text] [Related]
47. Malignancies arising in allograft kidneys, with a first reported translocation RCC post-transplantation: A case series.
Saleeb R; Faragalla H; Yousef GM; Stewart R; Streutker CJ
Pathol Res Pract; 2015 Aug; 211(8):584-7. PubMed ID: 26008778
[TBL] [Abstract][Full Text] [Related]
48. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
49. Prostate Cancer Dormancy and Reactivation in Bone Marrow.
Singh DK; Patel VG; Oh WK; Aguirre-Ghiso JA
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34208521
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological Characteristics and Short-Term Survival Analyses of Cutaneous Malignant Melanoma.
Ullah F; Jamshed M; Shakeel O; Khalid U; Khan R; Dhanani R; Mansoor R; Ullah S; Hussain R
Cureus; 2020 Aug; 12(8):e9868. PubMed ID: 32963909
[TBL] [Abstract][Full Text] [Related]
51. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
52. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
54. A clinicopathological and immunohistochemical correlation in cutaneous metastases from internal malignancies: a five-year study.
Nibhoria S; Tiwana KK; Kaur M; Kumar S
J Skin Cancer; 2014; 2014():793937. PubMed ID: 25215239
[TBL] [Abstract][Full Text] [Related]
55. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.
Eyles J; Puaux AL; Wang X; Toh B; Prakash C; Hong M; Tan TG; Zheng L; Ong LC; Jin Y; Kato M; Prévost-Blondel A; Chow P; Yang H; Abastado JP
J Clin Invest; 2010 Jun; 120(6):2030-9. PubMed ID: 20501944
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of Metastatic Tumor Dormancy.
Osisami M; Keller ET
J Clin Med; 2013 Sep; 2(3):136-50. PubMed ID: 26237067
[TBL] [Abstract][Full Text] [Related]
57. The Role of the ECM in Lung Cancer Dormancy and Outgrowth.
Parker AL; Cox TR
Front Oncol; 2020; 10():1766. PubMed ID: 33014869
[TBL] [Abstract][Full Text] [Related]
58. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
De Angelis ML; Francescangeli F; Zeuner A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
[TBL] [Abstract][Full Text] [Related]
59. Immunobiology of metastases.
Ioachim HL
Cancer Detect Prev; 1991; 15(2):127-31. PubMed ID: 2032253
[TBL] [Abstract][Full Text] [Related]
60. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
